MAR 25, 202654 MINS READ
Polyglycolic acid woven fiber is derived from polyglycolic acid (PGA), the simplest linear aliphatic polyester with repeating glycolic acid units (–OCH₂CO–) 3. The homopolymer exhibits a melting point of 215–225°C and a glass transition temperature (Tg) around 35–40°C, conferring thermal stability suitable for high-temperature processing 10. The crystalline structure of PGA is characterized by a triclinic unit cell with high chain packing density, which directly contributes to its exceptional tensile modulus (typically 7–10 GPa for drawn fibers) and gas impermeability 11.
In woven fiber applications, PGA is often blended with polylactic acid (PLA) at mass ratios of 70/30 to 99/1 (PGA/PLA) to mitigate fiber agglutination during storage and enhance processability without compromising biodegradability 12. The incorporation of high-molecular-weight PLA (Mw = 100,000–300,000 Da) suppresses the sticking tendency of undrawn PGA yarns under ambient humidity, a critical issue in conventional SDY methods 6. Copolymerization with lactide, ε-caprolactone, or trimethylene carbonate can further tailor degradation kinetics and mechanical compliance; for instance, poly(glycolide-co-lactide) (PLGA) at 90:10 glycolide/lactide ratio retains >85% of PGA's strength while exhibiting controlled hydrolysis over 4–6 months in vivo 3.
The fiber cross-sectional morphology is engineered to balance strength and surface area: typical PGA woven fibers possess diameters of 5–300 μm and a cross-sectional area ratio (fiber area/circumscribed circle area) of 10–95%, optimizing mechanical interlocking in woven structures and fluid permeability in well treatment applications 7. Molecular weight distribution (Mw/Mn = 1.5–3.0) is tightly controlled via ring-opening polymerization of glycolide to ensure uniform fiber properties and reproducible degradation profiles 1315.
High-purity glycolide, the cyclic dimer of glycolic acid, is the preferred monomer for PGA synthesis due to its ability to yield high-molecular-weight polymers (Mw > 200,000 Da) 13. Industrial glycolide production involves:
Alternative routes include direct synthesis from chloroacetic acid via hydrolysis and subsequent cyclization, though this method requires rigorous purification to remove chloride impurities that can catalyze chain scission during polymerization 14.
Glycolide undergoes ROP at 180–230°C in the presence of stannous octoate (Sn(Oct)₂, 0.01–0.1 wt%) or other metal catalysts (e.g., zinc, aluminum alkoxides) to produce PGA with Mw = 50,000–500,000 Da 110. Key process parameters include:
For woven fiber applications, the polymerized PGA is pelletized and subjected to solid-state polymerization (SSP) at 180–200°C under nitrogen to further increase Mw and crystallinity (up to 50–60%) without melting 17.
To enable storage-drawing processes, PGA resin is melt-blended with high-Mw PLA (100,000–300,000 Da) at 220–240°C in twin-screw extruders 12. The PLA component acts as a processing aid by:
The PGA or PGA/PLA blend is extruded through spinnerets (hole diameter 0.2–0.5 mm, L/D ratio 3–5) at 230–250°C and take-up speeds of 500–1,500 m/min to form undrawn yarns 18. A critical innovation involves a heat retention step immediately post-extrusion: the fibrous melt is maintained at 110.5–220°C for ≥0.0012 seconds in a heated chamber before quenching, which promotes partial crystallization (15–25%) and reduces brittleness during subsequent handling 812. This step is essential for achieving drawable undrawn yarns with elongation at break >200% and single-filament fineness of 1–10 denier 12.
Rapid cooling (air quench at 15–25°C) then solidifies the fiber structure, yielding undrawn yarns with:
Unlike conventional SDY methods, modern PGA fiber production incorporates a storage step where undrawn yarns are wound onto bobbins and kept at 1–20°C for 1–30 days 45. This decouples spinning from drawing, enabling:
To prevent agglutination (fiber sticking due to surface tackiness), two strategies are employed:
Experimental data show that 95/5 PGA/PLA yarns stored at 5°C for 14 days exhibit zero agglutination and retain 98% drawability, whereas pure PGA yarns agglutinate within 48 h at 20°C 6.
Stored undrawn yarns are drawn at 60–100°C (above Tg but below Tm) using multi-stage rollers at draw ratios of 3.0–5.5× 12. The drawing process:
For ultra-fine fibers (<1 denier per filament), a two-step drawing protocol is used: initial draw at 70°C (3.0×) followed by annealing at 150°C under tension (1.5×), yielding fibers with strength >10 gf/D and modulus >150 GPa 12.
Drawn PGA yarns (typically 50–150 denier, 20–100 filaments) are woven into fabrics using conventional looms (plain, twill, or satin weaves) or knitted into tubular structures 18. Key considerations include:
For tissue engineering scaffolds, PGA woven fabrics are often felted with polyethylene terephthalate (PET) supports at edges to provide mechanical anchoring during bioreactor culture 18.
Drawn PGA woven fibers exhibit:
These properties are retained up to 80°C; above 100°C, tensile strength decreases by ~20% due to onset of chain mobility 10.
PGA woven fibers degrade via hydrolytic cleavage of ester bonds, with kinetics strongly dependent on temperature, pH, and crystallinity:
Thermogravimetric analysis (TGA) shows onset of thermal decomposition at 320–340°C (5% weight loss), with maximum degradation rate at 380–400°C 10. Differential scanning calorimetry (DSC) reveals a single melting endotherm at 220–225°C (ΔHm = 120–140 J/g for highly crystalline fibers) 8.
PGA woven fibers (when densified into films or coatings) exhibit oxygen transmission rates (OTR) of 0.5–2.0 cm³/(m²·day·atm) at 23°C and 0% RH, superior to PLA (50–150 cm³/(m²·day·atm)) and comparable to EVOH 11. This property is exploited in biodegradable packaging and controlled-release drug delivery systems.
Untreated PGA fibers are moderately hydrophobic (water contact angle 65–75°) due to crystalline surface domains 18. Alkaline treatment (1 M NaOH, 60°C, 30 min) reduces contact angle to <20° by hydrolyzing surface ester groups to carboxylates, enhancing cell adhesion in tissue engineering scaffolds 18. Surface roughness (Ra) increases from 50–80 nm (as-spun) to 200–400 nm (alkali-treated), promoting mechanical interlocking with extracellular matrix proteins 18.
PGA woven fibers dominate the bioabsorbable suture market due to their combination of high initial strength and predictable degradation:
R&D recommendations: Investigate surface functionalization with RGD peptides or growth factors to enhance osteoblast/fibroblast attachment; explore PGA/hydroxyapatite composites for load-bearing bone scaffolds.
PGA woven fibers are engineered for temporary downhole applications where rapid degradation at elevated temperatures (90–150°C) is advantageous:
Performance data: In field trials, PGA fiber
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| Kureha Corporation | Mass production of biodegradable fibers for medical sutures, tissue engineering scaffolds, and oil well completion applications requiring cost-effective manufacturing and predictable degradation. | PGA/PLA Blended Fiber | Storage-drawing process with PGA/PLA blend (70/30-99/1 ratio) prevents fiber agglutination, increases production throughput by 3-5× compared to SDY method, maintains tensile strength of 5.0-7.5 cN/dtex and complete degradation within 180 days at 37°C. |
| Kureha Corporation | Hydraulic fracturing fluid additives and dissolvable bridge plugs in oil and gas well completion, providing temporary mechanical isolation (5,000-10,000 psi) and natural degradation at high-temperature reservoir environments (90-150°C). | PGA Short Fibers for Well Treatment | Engineered short fibers (5-300 μm diameter, 1-30 mm length, 1-20 gf/D strength) achieve 90% mass loss within 7 days at 120°C downhole conditions, excellent proppant dispersibility at 30-40 lbm/Mgal concentration, eliminate need for mechanical retrieval. |
| Kureha Corporation | High-performance surgical sutures (USP size 2-0 to 6-0) retaining 70% tensile strength at 14 days post-implantation, orthopedic fixation devices, and precision medical applications requiring ultra-fine diameter and exceptional mechanical properties. | Ultra-fine PGA Drawn Yarn | Heat retention process (110.5-220°C for ≥0.0012 seconds post-extrusion) enables production of ultra-fine fibers (<1 denier per filament) with tensile strength >10 gf/D, Young's modulus >150 GPa, and elongation at break of 15-30% through controlled crystallization. |
| Humacyte | Vascular tissue engineering and regenerative medicine applications requiring biodegradable scaffolds for cell seeding and cultivation, producing functional tissue-engineered blood vessels with mechanical properties suitable for clinical implantation. | Tubular PGA Tissue Engineering Scaffold | Felted tubular PGA constructs (4-6 mm inner diameter, 45-75 mg/cc seam density, porosity 85-95%) treated with 1M NaOH to reduce water contact angle from 75° to <20°, generate tissue-engineered blood vessels with burst pressures >2,000 mmHg after 8-week bioreactor culture. |
| Smith & Nephew PLC | Bioabsorbable surgical implants, drug delivery systems, and tissue engineering scaffolds for applications requiring extended degradation profiles, predictable mechanical property retention, and complete in vivo absorption without foreign body response. | PLGA Copolymer Medical Scaffold | Poly(glycolide-co-lactide) copolymer at 85:15 to 99:1 PGA:PLA ratio retains >85% of pure PGA strength while exhibiting controlled hydrolysis over 4-6 months in vivo, complete resorption with non-toxic degradation products (glycolic acid metabolized to water and CO2). |